Analyse PetMed Express, Inc. (PETS) — Kairos Score 35/100

À propos de PetMed Express, Inc.

PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards. The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.

Informations clés

🕴️ Activité des initiés (90 jours)

4 transactions — 0 achats et 0 ventes déclarés par les dirigeants de PetMed Express, Inc..

🏦 Hedge Funds

15 fonds institutionnels déclarent une position sur PETS dans leur dernière déclaration trimestrielle SEC.

📰 Actualités récentes

15 articles récents sur PETS.

• PetMeds Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• PetMeds Enhances Board of Directors with Appointment of Tamar Elkeles as New Independent Director

🧠 Ce qui fait Kairos Insider

Au-dela des donnees brutes, nous agregeons et scoring tout le signal smart money pour vous donner une vue unique.